Feature | Coronavirus (COVID-19) | February 28, 2020

Emerging Technologies Proving Value in Chinese Coronavirus Fight

AI vendor Infervision's InferRead CT Pneumonia software uses artificial intelligence-assisted diagnosis tp improve the overall efficiency of the radiology department. It is being delayed in China as a high sensitivity detection aid for novel coronavirus pneumonia (COVID-19). #COVID-19 #COVID19 #Coronavirus #2019-nCoV

AI vendor Infervision's InferRead CT Pneumonia software uses artificial intelligence-assisted diagnosis to improve the overall efficiency of the radiology department. It is being developed in China as a high sensitivity detection aid for novel coronavirus pneumonia (COVID-19).

February 28, 2020 — New healthcare technologies are being implemented in the fight against the novel coronavirus (COVID-19) outbreak in China. This new tech includes artificial intelligence, analytics software, and using drones to make deliveries to hospitals, according to the healthcare market research firm GlobalData

The first reports of the 2019 novel coronavirus (2019-nCoV) from Wuhan, China were made Dec. 31, 2019, and it quickly spread to become a global emergency. The number of deaths due to COVID-19 in China has already exceeded the SARS outbreak in 2003. Against this backdrop, tech startups are working with government agencies, clinicians and academics to help contain the outbreak, said GlobalData.

“China is becoming the largest testing ground to demonstrate how emerging technologies can be harnessed to improve epidemic management and minimize the economic impact of the coronavirus outbreak,” explained Venkata Naveen, disruptive tech analyst at GlobalData. “With coronavirus pushing China’s health system into turmoil, the country is deploying tech solutions like never before to overcome its worst crisis in years. The ongoing epidemic has once again reiterated how important emerging technologies are in predicting and combating the spread of infectious diseases.” 

The Innovation Explorer database of GlobalData’s Disruptor Intelligence Center reveals various crucial use cases of emerging technologies to fight the coronavirus:

 

Artificial Intelligence to Monitor Coronavirus Outbreak Analytics

Artificial Intelligence (AI) can be used to identify disease outbreaks as well as forecast their nature of spread. Canadian startup BlueDot used AI and machine learning to detect the coronavirus outbreak even before the Chinese authorities. Its AI algorithm analyzed multiple sources such as news reports, social media platforms and government documents to predict the outbreak. 

 

AI to Help Diagnose Coronavirus on CT Scans

AI developer Infervision launched a coronavirus artificial intelligence solution in China this past month that is tailored for front-line use to help clinicians detect and monitor the disease more effectively. The outbreak has put significant pressure on imaging departments, which are now reading over a thousand cases a day. Patients and clinicians typically have to wait a few hours to get the CT results, but Infervision AI is improving the CT diagnosis speed for each case. The surging number of patients needing diagnosis and the strict laboratory requirements for the use of the rRT-PCR detection kit, to confirm the 2019-nCoV diagnosis, pose big challenges to regional and rural hospitals. Infervision’s tools are helping sites with limited medical resources to immediately screen out suspected Coronavirus-infected patients for further diagnosis and treatment.
 

Sterilization Robots Help Clean Coronavirus Quarantine Wards

Autonomous sterilization robots are helping hospitals to contain the infections in quarantined wards by easily moving into a quarantined zone to sterilize virus without human intervention. Chinese medical robot developer TMiRob deployed 10 disinfection robots across major hospitals in Wuhan to contain the spread of COVID-19. 

Claims Processing To Speed Administrative Paperwork Processing

Blockchain-powered services are helping hospitals to reduce the time spent on administrative work and allocate staff to the frontlines. China’s Xiang Hu Bao, owned by Ant Financial, is offering a blockchain platform to speed up the claims processing, reducing the need for face-to-face contact amidst the coronavirus outbreak.

Drones Offer Aerial Delivery of Medical Supplies In Coronavirus Hit Areas

Drones are gaining popularity as the fastest and safest means to transport supplies during disease outbreaks. Singapore’s AI startup Antwork has launched the first ‘urban air transportation channel’ to deliver medical supplies between Xinchang County People’s Hospital and the county’s disease control center, both located in Zhejiang, one of the most severely coronavirus hit provinces.

Chatbots Used to Pass Along Coronavirus Travel Alerts

Chatbots are becoming the real-time information providers of coronavirus outbreak. Japan’s startup Bespoke has launched a chatbot "Bebot" to offer latest and reliable updates to travelers on the coronavirus outbreak. Accessed through a mobile app, it can answer queries on coronavirus such as symptoms, preventative measures and treatment procedures.

On the other side, China’s tech leaders Baidu, Alibaba and Tencent have also joined the fight against the outbreak. Baidu has open-sourced its RNA prediction algorithm LinearFold to help researchers accelerate the time taken to predict the virus’s RNA secondary structure from 55 minutes to 27 seconds.

Alibaba launched a new AI-based system to detect coronavirus infection via CT scans with an accuracy of up to 96% in less than 20 seconds. Alibaba’s Alipay and Tencent’s WeChat released a feature to track individuals affected with the coronavirus using colored QR codes.

Additional Coronavirus Resources for Clinicians:

   • World Health Organization (WHO) COVID-19 situation reports.

   • World Health Organization (WHO) coronavirus information page

   • U.S. Food and Drug Administration (FDA) COVID-19 information page

   • Centers for Disease Control (CDC) COVID-19 information page

 

Related Coronavirus Content:

The Cardiac Implications of Novel Coronavirus

Radiologists Describe Coronavirus CT Imaging Features

Coronavirus Update from the FDA

CT Imaging of the 2019 Novel Coronavirus (2019-nCoV) Pneumonia

Infervision in the Frontlines Against the Coronavirus

CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV)

Chest CT Findings of Patients Infected With Novel Coronavirus 2019-nCoV Pneumonia 

Find more related clinical content Coronavirus (COVID-19)

FDA Resource on the Novel coronavirus (COVID-19)

Mount Sinai Physicians the First in U.S. Analyzing Lung Disease in Coronavirus Patients from China

Related Content

#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2 U.S. Surgeon General Jerome Adams, M.D., M.Ph demonstrates how the general public can make their own face masks for non-clinical use.

U.S. Surgeon General Jerome Adams, M.D., M.Ph. demonstrates how the general public can make their own face masks for non-clinical use.

News | Coronavirus (COVID-19) | April 04, 2020 | By Melinda Taschetta-Millane
April 4, 2020 — The Centers for Disease Control and Prevention (CDC)
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2

Getty Images

Feature | Coronavirus (COVID-19) | April 03, 2020 | By Melinda Taschetta-Millane and Dave Fornell
In an effort to keep the imaging field updated on the latest information being released on coronavirus (COVID-19), th
Varian received FDA clearance for its Ethos therapy in February 2020. It is an adaptive intelligence solution that uses onboard AI in the treatment system to take the cone beam CT imaging on the system, compare it to the treatment plan and deliver an entire adaptive treatment plan in a typical 15-minute treatment time slot, from patient setup through treatment delivery.

Varian received FDA clearance for its Ethos therapy in February 2020, shown here displayed for the first time at ASTRO 2019. It is an adaptive intelligence solution that uses onboard AI in the treatment system to take the cone beam CT imaging on the system, compare it to the treatment plan and deliver an entire adaptive treatment plan in a typical 15-minute treatment time slot, from patient setup through treatment delivery.

Feature | Treatment Planning | April 03, 2020 | Dave Fornell, Editor
The traditional treatment planning process takes days to create an optimized radiation therapy delivery plan, but new
Recommended best practices for nuclear imaging departments under the COVIF-19 pandemic have been issues by the ASNC and SNMMI. #COVID19 #ASNC #SNMMI #Coronavirus #SARScov2
News | Coronavirus (COVID-19) | April 03, 2020
April 3, 2020 — A new guidance document on best practices to maintain safety and minimize contamination in nuclear im
Jeannie Danker, M.D. #COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2

Jeannie Danker, M.D. Photo courtesy of The Ohio State University Wexner Medical Center

News | Coronavirus (COVID-19) | April 03, 2020 | By Melinda Taschetta-Millane
April 3, 2020 — The radiology world has lost a dedicated leader due to...
An example of Philips’ TrueVue technology, which offers photo-realistic rendering and the ability to change the location of the lighting source on 3-D ultrasound images. In this example of two Amplazer transcatheter septal occluder devices in the heart, the operator demonstrating the product was able to push the lighting source behind the devices into the other chamber of the heart. This illuminated a hole that was still present that the occluders did not seal.

An example of Philips’ TrueVue technology, which offers photo-realistic rendering and the ability to change the location of the lighting source on 3-D ultrasound images. In this example of two Amplazer transcatheter septal occluder devices in the heart, the operator demonstrating the product was able to push the lighting source behind the devices into the other chamber of the heart. This illuminated a hole that was still present that the occluders did not seal. Photo by Dave Fornell

Feature | Radiology Imaging | April 02, 2020 | By Katie Caron
A new year — and decade — offers the opportunity to reflect on the advancements and challenges of years gone by and p
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus

Getty Images

Feature | Coronavirus (COVID-19) | April 02, 2020 | Jilan Liu and HIMSS Greater China Team
Information technologies have played a pivotal role in China’s response to the novel coronavirus...
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2 Esaote won a tender launched by Consip on behalf of Civil Protection for the distribution of diagnostic equipment in Italy to face COVID-19 emergency.

Esaote won a tender launched by Consip on behalf of Civil Protection for the distribution of diagnostic equipment in Italy to face COVID-19 emergency.

News | Ultrasound Imaging | April 02, 2020
April 2, 2020 — Esaote, an Italian company among the world leader
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2 Updated CT scoring criteria from AJR considers both lobe involvement and changes in CT findings to quantitatively and accurately evaluate the progression of COVID-19 pneumonia

CT scoring criteria were applied to images from sequential chest CT examinations. A, Initial chest CT image obtained 2 days after onset of symptoms shows small region of subpleural ground-glass opacities in right lower lobe, for CT score of 1. B, Chest CT image obtained on day 3 of treatment shows slightly enlarged region of subpleural ground-glass opacities with partial crazy-paving pattern and consolidation, for CT score of 3. C, Chest CT image obtained on day 5 of treatment shows partial resolution of consolidation, for CT score of 2. D, Chest CT image obtained on day 14 of treatment shows continued resolution of consolidation with minimal residual ground-glass opacities, for CT score of 1. Image courtesy of American Journal of Roentgenology (AJR)

News | Computed Tomography (CT) | April 02, 2020
April 2, 2020 — Updated computed t...